Pyxis Oncology, Inc. Quarterly Common Stock, Shares Authorized from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Pyxis Oncology, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2020 to Q2 2024.
  • Pyxis Oncology, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 190M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 190M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 190M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 190M 0 0% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 190M 0 0% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 190M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 190M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 190M 0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 190M +23M +13.8% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 190M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 190M Mar 31, 2022 10-Q 2022-05-13
Q4 2021 190M +150M +371% Dec 31, 2021 10-K 2023-03-22
Q3 2021 167M Sep 30, 2021 10-Q 2021-11-15
Q4 2020 40.3M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.